Morpholino

MO5-esr2a

ID
ZDB-MRPHLNO-181211-1
Name
MO5-esr2a
Previous Names
None
Target
Sequence
5' - GAGTTCAGAGCTGTCGCATCAGTAA - 3'
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
None
Genome Resources
None
Target Location
Genomic Features
No data available
Expression
Gene expression in Wild Types + MO5-esr2a
No data available
Phenotype
Phenotype resulting from MO5-esr2a
No data available
Phenotype of all Fish created by or utilizing MO5-esr2a
Phenotype Fish Conditions Figures
liver GFP expression amount, ameliorated u300Tg/u300Tg; uex3Tg/uex3Tg + MO2-esr2b + MO5-esr2a chemical treatment by environment: 17-alpha-Ethinylestradiol Fig. 3 from Moreman et al., 2018
trunk somite GFP expression amount, ameliorated u300Tg/u300Tg; uex3Tg/uex3Tg + MO2-esr2b + MO5-esr2a chemical treatment by environment: 17-alpha-Ethinylestradiol Fig. 3 from Moreman et al., 2018
trunk somite GFP expression increased amount, abnormal u300Tg/u300Tg; uex3Tg/uex3Tg + MO2-esr2b + MO5-esr2a chemical treatment by environment: bisphenol A Fig. 3 from Moreman et al., 2018
liver GFP expression amount, ameliorated u300Tg/u300Tg; uex3Tg/uex3Tg + MO2-esr2b + MO5-esr2a chemical treatment by environment: bisphenol A Fig. 3 from Moreman et al., 2018
liver GFP expression amount, ameliorated u300Tg/u300Tg; uex3Tg/uex3Tg + MO2-esr2b + MO5-esr2a chemical treatment by environment: 4-Methyl-2,4-bis-(p-hydroxyphenyl)pent-1-ene Fig. 3 from Moreman et al., 2018
trunk somite GFP expression amount, ameliorated u300Tg/u300Tg; uex3Tg/uex3Tg + MO2-esr2b + MO5-esr2a chemical treatment by environment: 4-Methyl-2,4-bis-(p-hydroxyphenyl)pent-1-ene Fig. 3 from Moreman et al., 2018
caudal fin somite GFP expression amount, ameliorated u300Tg/u300Tg; uex3Tg/uex3Tg + MO2-esr2b + MO5-esr2a chemical treatment by environment: 17-alpha-Ethinylestradiol Fig. 3 from Moreman et al., 2018
heart GFP expression amount, ameliorated u300Tg/u300Tg; uex3Tg/uex3Tg + MO2-esr2b + MO5-esr2a chemical treatment by environment: 17-alpha-Ethinylestradiol Fig. 3 from Moreman et al., 2018
heart GFP expression amount, ameliorated u300Tg/u300Tg; uex3Tg/uex3Tg + MO2-esr2b + MO5-esr2a chemical treatment by environment: bisphenol A Fig. 3 from Moreman et al., 2018
caudal fin somite GFP expression amount, ameliorated u300Tg/u300Tg; uex3Tg/uex3Tg + MO2-esr2b + MO5-esr2a chemical treatment by environment: bisphenol A Fig. 3 from Moreman et al., 2018
caudal fin somite GFP expression amount, ameliorated u300Tg/u300Tg; uex3Tg/uex3Tg + MO2-esr2b + MO5-esr2a chemical treatment by environment: 4-Methyl-2,4-bis-(p-hydroxyphenyl)pent-1-ene Fig. 3 from Moreman et al., 2018
heart GFP expression amount, ameliorated u300Tg/u300Tg; uex3Tg/uex3Tg + MO2-esr2b + MO5-esr2a chemical treatment by environment: 4-Methyl-2,4-bis-(p-hydroxyphenyl)pent-1-ene Fig. 3 from Moreman et al., 2018
Citations